Are KYC And AML Regulations The Missing Trust Layer In Digital Finance?

Are KYC and AML regulations the missing trust layer? Know how identity verification and monitoring secure digital finance and ...
The American Journal of Managed Care

Top 5 Most-Read ALL/AML Articles in 2024

Fatigue is a key prognostic indicator for adverse outcomes in AML, ALL, and myelodysplastic syndromes. CAR T-cell therapy post-transplant shows a 48% complete remission rate in AML, though not ...
The American Journal of Managed Care

All Oral Regimens in AML: Future Sequencing Implications

Panelists discuss how future AML treatment will likely involve sophisticated decisions about triplet combinations, optimal sequencing of targeted agents, and balancing efficacy with toxicity through ...
Seeking Alpha

SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study

The Trial Exceeded Target Overall Response Rate (ORR) of 20%, with 44% Response Rate Among Patients with Acute Myeloid Leukemia-Myelodysplasia-Related Changes (AML MR) Treated at Optimal Dose of 30 mg ...
Cure Today

SLS009 May Improve Survival in R/R AML

SLS009 significantly improved survival in r/r AML patients, with a median overall survival of 8.8 months, surpassing historical benchmarks. The therapy showed a 67% objective response rate in AML-MRC ...